Ranbaxy drugs are safe: South African regulator

Updated - November 16, 2021 11:56 pm IST

Published - June 05, 2013 11:45 pm IST - JOHANNESBURG

Generic drugs distributed in South Africa by Ranbaxy Laboratories are ‘safe’ and ‘efficacious’, the country’s regulator body said on Wednesday, days after the beleaguered drug maker paid a fine of $500 million in the U.S. for selling adulterated drugs there.

“We are confident that drugs now on the market are safe, efficacious and of quality,” Mandisa Hela, Registrar of the South African Medicines Control Council (MCC), told the daily Business Day here.

Ms. Hela said representatives from the regulator and those from the World Health Organization, the U.K. Medicines and Healthcare Products Regulatory Agency and the Australian Therapeutic Goods Authority, had inspected Ranbaxy’s manufacturing sites and were satisfied.

The South African subsidiary of India’s largest pharmaceutical company has also issued a similar statement, assuring the public that drugs manufactured locally are safe.

This assurance came after the drug maker paid a fine in the U.S. for falsifying data and selling sub-standard drugs manufactured at two of its plants in India.

Ms. Hela told the daily that the MCC had inspected a clinical research organisation in India called Vimta Laboratories that did work for Ranbaxy and rival generic manufacturer Cipla.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.